Digital health technology in clinical trials

被引:14
|
作者
Mittermaier, Mirja [1 ,2 ,3 ,4 ]
Venkatesh, Kaushik P. [5 ]
Kvedar, Joseph C. [5 ]
机构
[1] Charite Univ Med Berlin, Dept Infect Dis Resp Med & Crit Care, Berlin, Germany
[2] Free Univ Berlin, Berlin, Germany
[3] Humboldt Univ, Berlin, Germany
[4] Charite Univ Med Berlin, Berlin Inst Hlth, Charitepl 1, D-10117 Berlin, Germany
[5] Harvard Med Sch, Boston, MA USA
关键词
Compendex;
D O I
10.1038/s41746-023-00841-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Digital health technologies (DHTs) have brought several significant improvements to clinical trials, enabling real-world data collection outside of the traditional clinical context and more patient-centered approaches. DHTs, such as wearables, allow the collection of unique personal data at home over a long period. But DHTs also bring challenges, such as digital endpoint harmonization and disadvantaging populations already experiencing the digital divide. A recent study explored the growth trends and implications of established and novel DHTs in neurology trials over the past decade. Here, we discuss the benefits and future challenges of DHT usage in clinical trials.
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Using digital technology to support and enhance clinical trials in resource-limited settings
    Lang, T.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 49 - 49
  • [22] Digital mammography: Clinical implementation and clinical trials
    D'Orsi, Carl J.
    Newell, Mary S.
    SEMINARS IN ROENTGENOLOGY, 2007, 42 (04) : 236 - 242
  • [23] Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies
    Spencer Phillips Hey
    Maria Dellapina
    Kristin Lindquist
    Bert Hartog
    Jason LaRoche
    Therapeutic Innovation & Regulatory Science, 2023, 57 : 1269 - 1278
  • [24] Digital Health Technologies in Clinical Trials: An Ontology-Driven Analysis to Inform Digital Sustainability Policies
    Hey, Spencer Phillips
    Dellapina, Maria
    Lindquist, Kristin
    Hartog, Bert
    LaRoche, Jason
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2023, 57 (06) : 1269 - 1278
  • [25] Digital health technology derived measures: Biomarkers or clinical outcome assessments?
    Izmailova, Elena S.
    Demanuele, Charmaine
    McCarthy, Marie
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (07): : 1113 - 1120
  • [26] OPPORTUNITIES AND CHALLENGES FOR DECENTRALIZED CLINICAL TRIALS: EUROPEAN HEALTH TECHNOLOGY ASSESSMENT PERSPECTIVE
    de Jong, A.
    Shahid, N.
    Zuidgeest, M.
    Santa-Ana-Tellez, Y.
    Hogervorst, M.
    Goettsch, W. G.
    Traore, H.
    de Boer, A.
    Gardarsdottir, H.
    VALUE IN HEALTH, 2023, 26 (12) : S557 - S557
  • [27] HEALTH TECHNOLOGY ASSESSMENTS OF SINGLE-ARM CLINICAL TRIALS IN GERMANY AND FRANCE
    Heidbrede, T.
    Basic, E.
    Bussilliat, P.
    Dintsios, C. M.
    VALUE IN HEALTH, 2022, 25 (12) : S347 - S347
  • [28] Digital Health Technologies in Pediatric Trials
    Leonard Sacks
    Elizabeth Kunkoski
    Marianne Noone
    Therapeutic Innovation & Regulatory Science, 2022, 56 : 929 - 933
  • [29] Digital Health Technologies in Pediatric Trials
    Sacks, Leonard
    Kunkoski, Elizabeth
    Noone, Marianne
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (06) : 929 - 933
  • [30] Digital health technologies and Alzheimer's disease clinical trials: might decentralized clinical trials increase participation by people with cognitive impairment?
    Leroy, Victoire
    Gana, Wassim
    Aidoud, Amal
    N'kodo, Jacques-Alexis
    Balageas, Anna-Chloe
    Blanc, Pascal
    Bomia, Dominique
    Debacq, Camille
    Fougere, Bertrand
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)